BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 34917730)

  • 41. Uptake of risk-reducing surgery in BRCA gene carriers in Wales, UK.
    Long J; Evans TG; Bailey D; Lewis MH; Gower-Thomas K; Murray A
    Breast J; 2018 Jul; 24(4):580-585. PubMed ID: 29286205
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Prophylactic mastectomy in BRCA1/2 mutation carriers and women at risk of hereditary breast cancer: long-term experiences at the Rotterdam Family Cancer Clinic.
    Heemskerk-Gerritsen BA; Brekelmans CT; Menke-Pluymers MB; van Geel AN; Tilanus-Linthorst MM; Bartels CC; Tan M; Meijers-Heijboer HE; Klijn JG; Seynaeve C
    Ann Surg Oncol; 2007 Dec; 14(12):3335-44. PubMed ID: 17541692
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Clinical characteristics and outcomes in elderly women with BRCA1 and BRCA2 mutations.
    Salyer C; Kobelka C; Barrie A; Weintraub MR; Powell CB
    Gynecol Oncol; 2019 Aug; 154(2):374-378. PubMed ID: 31160070
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Canadian cost-effectiveness model of BRCA-driven surgical prevention of breast/ovarian cancers compared to treatment if cancer develops.
    Hurry M; Eccleston A; Dyer M; Hoskins P
    Int J Technol Assess Health Care; 2020 Apr; 36(2):104-112. PubMed ID: 32423520
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Risk of epithelial ovarian cancer in asymptomatic women with ultrasound-detected ovarian masses: a prospective cohort study within the UK collaborative trial of ovarian cancer screening (UKCTOCS).
    Sharma A; Apostolidou S; Burnell M; Campbell S; Habib M; Gentry-Maharaj A; Amso N; Seif MW; Fletcher G; Singh N; Benjamin E; Brunell C; Turner G; Rangar R; Godfrey K; Oram D; Herod J; Williamson K; Jenkins H; Mould T; Woolas R; Murdoch J; Dobbs S; Leeson S; Cruickshank D; Fourkala EO; Ryan A; Parmar M; Jacobs I; Menon U
    Ultrasound Obstet Gynecol; 2012 Sep; 40(3):338-44. PubMed ID: 22911637
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Prophylactic irradiation to the contralateral breast for BRCA mutation carriers with early-stage breast cancer.
    Evron E; Ben-David AM; Goldberg H; Fried G; Kaufman B; Catane R; Pfeffer MR; Geffen DB; Chernobelsky P; Karni T; Abdah-Bortnyak R; Rosengarten O; Matceyevsky D; Inbar M; Kuten A; Corn BW
    Ann Oncol; 2019 Mar; 30(3):412-417. PubMed ID: 30475942
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Germline mutations in Thai patients with nonmucinous epithelial ovarian cancer.
    Manchana T; Phowthongkum P; Teerapakpinyo C
    World J Clin Oncol; 2019 Nov; 10(11):358-368. PubMed ID: 31815095
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Ten-year survival after epithelial ovarian cancer is not associated with BRCA mutation status.
    Kotsopoulos J; Rosen B; Fan I; Moody J; McLaughlin JR; Risch H; May T; Sun P; Narod SA
    Gynecol Oncol; 2016 Jan; 140(1):42-7. PubMed ID: 26556769
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Disparities between Uptake of Germline
    Hur YM; Mun J; Kim MK; Lee M; Kim YH; Kim SC
    J Korean Med Sci; 2021 Oct; 36(38):e241. PubMed ID: 34609091
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Identification of Eleven Novel
    Hamdi Y; Mighri N; Boujemaa M; Mejri N; Ben Nasr S; Ben Rekaya M; Messaoud O; Bouaziz H; Berrazega Y; Rachdi H; Jaidane O; Daoud N; Zribi A; Ayari J; El Benna H; Labidi S; Ben Hassouna J; Haddaoui A; Rahal K; Benna F; Mrad R; Ben Ahmed S; Boussen H; Boubaker S; Abdelhak S
    Front Oncol; 2021; 11():674965. PubMed ID: 34490083
    [TBL] [Abstract][Full Text] [Related]  

  • 51. BRCA1 and BRCA2 mutations as prognostic factors in bilateral breast cancer patients.
    Rogozińska-Szczepka J; Utracka-Hutka B; Grzybowska E; Maka B; Nowicka E; Smok-Ragankiewicz A; Zientek H; Steffen J; Wojciechowska-Łacka A
    Ann Oncol; 2004 Sep; 15(9):1373-6. PubMed ID: 15319244
    [TBL] [Abstract][Full Text] [Related]  

  • 52. BRCA1/2 mutations and expression: response to platinum chemotherapy in patients with advanced stage epithelial ovarian cancer.
    Dann RB; DeLoia JA; Timms KM; Zorn KK; Potter J; Flake DD; Lanchbury JS; Krivak TC
    Gynecol Oncol; 2012 Jun; 125(3):677-82. PubMed ID: 22406760
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Uptake and timing of risk-reducing salpingo-oophorectomy among patients with BRCA1 and BRCA2 mutations.
    Smith MJ; Gerber D; Olsen A; Khouri OR; Wang Y; Liu M; Smith J; Pothuri B
    Am J Obstet Gynecol; 2021 Nov; 225(5):508.e1-508.e10. PubMed ID: 34171390
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Radiation-Associated Secondary Malignancies in BRCA Mutation Carriers Treated for Breast Cancer.
    Schlosser S; Rabinovitch R; Shatz Z; Galper S; Shahadi-Dromi I; Finkel S; Jacobson G; Rasco A; Friedman E; Laitman Y; Evron E; Bernstein R; Weiss I; Sklair-Levy M; Ben-David MA
    Int J Radiat Oncol Biol Phys; 2020 Jun; 107(2):353-359. PubMed ID: 32084523
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Dominant-negative pathogenic variant BRIP1 c.1045G>C is a high-risk allele for non-mucinous epithelial ovarian cancer: A case-control study.
    Flaum N; van Veen EM; Smith O; Amico S; Newman WG; Crosbie EJ; Edmondson R; Smith MJ; Evans DG
    Clin Genet; 2022 Jan; 101(1):48-54. PubMed ID: 34585738
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Prevalence of
    Ataseven B; Tripon D; Rhiem K; Harter P; Schneider S; Heitz F; Baert T; Traut A; Pauly N; Ehmann S; Plett H; Schmutzler RK; du Bois A
    Geburtshilfe Frauenheilkd; 2020 Sep; 80(9):932-940. PubMed ID: 32905297
    [No Abstract]   [Full Text] [Related]  

  • 57. Genetic testing of breast and ovarian cancer patients: clinical characteristics and hormonal risk modifiers.
    Kaduri L; Gibs M; Hubert A; Sagi M; Heching N; Lerer I; Uziely B; Weinberg N; Abeliovich D; Peretz T
    Eur J Obstet Gynecol Reprod Biol; 1999 Jul; 85(1):75-80. PubMed ID: 10428326
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Synchronous and Metachronous Breast and Ovarian Cancer: Experience From Two Large Cancer Center.
    Tasca G; Dieci MV; Baretta Z; Faggioni G; Montagna M; Nicoletto MO; Peccatori FA; Guarneri V; Colombo N
    Front Oncol; 2020; 10():608783. PubMed ID: 33381461
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Trends and timing of risk-reducing mastectomy uptake in unaffected BRCA1 and BRCA2 carriers in Slovenia.
    Ložar T; Žgajnar J; Perhavec A; Blatnik A; Novaković S; Krajc M
    Eur J Surg Oncol; 2021 Aug; 47(8):1900-1906. PubMed ID: 33812767
    [TBL] [Abstract][Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.